imphatec

imphatec is a drug delivery company developing subcutaneous implants that release medicines steadily for up to a year, with the aim of replacing daily tablets for people managing chronic and long-term conditions.

Its implants are formulated to deliver a customised daily dose of a drug from a polymer matrix placed under the skin.

The company's initial programmes include long-acting hormone delivery, with a focus on conditions that disproportionately affect women.